AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IRBESARTAN 300 Mg ;
12 registrations across 1 African market— 12 active
Markets with IRBESARTAN 300 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| APROVEL® 300mg Film Coated Tablets | 🇪🇬Egypt | SANOFI scientific office | active | — |
| APROVEL® 300mg Film Coated Tablets | 🇪🇬Egypt | SANOFI scientific office | active | — |
| Angioblock Mono 300 mg Tablets | 🇪🇬Egypt | Global Advanced pharmaceuticals "GAP" | active | — |
| Irbesartan 300 mg Film Coated Tablets | 🇪🇬Egypt | Arab Company for Pharmaceuticals and Medicinal Plants _ Mepaco- Medi Food | active | — |
| Irbedrin ® 300 mg Tablets | 🇪🇬Egypt | Medical Union Pharmaceuticals - MUP | active | — |
| Kansartan 300 mg Tablets | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| X –Tension 300 mg Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Angioblock Mono 300 mg Tablets | 🇪🇬Egypt | Global Advanced pharmaceuticals "GAP" | active | — |
| Irbesartan 300 mg Film Coated Tablets | 🇪🇬Egypt | Arab Company for Pharmaceuticals and Medicinal Plants _ Mepaco- Medi Food | active | — |
| Kansartan 300 mg Tablets | 🇪🇬Egypt | Chemipharm Pharmaceutical Industries | active | — |
| X –Tension 300 mg Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Irbedrin ® 300 mg Tablets | 🇪🇬Egypt | Medical Union Pharmaceuticals - MUP | active | — |
IRBESARTAN 300 Mg ; in Africa — Regulatory Overview
IRBESARTAN 300 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.